Urinary iodine in patients with auto-immune thyroid disorders in Santo André, SP, is comparable to normal controls and has been steady for the last 10 years;A iodúria de pacientes portadores de tireopatias autoimunes em Santo André, SP, é comparável à dos indivíduos normais e estável nos últimos dez anos

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 53, Issue 1, 2009, Pages 55-63

  Marino, Maria Angela Zaccarelli ^a   Martins, Lourdes Conceição ^a,b   Esteves, Roberto Z ^c   Kasamatsu, Teresa S ^c   Maciel, Rui M B ^c  

^a FACULDADE DE MEDICINA DO ABC   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Amiodarone; Chronic auto immune thyroiditis; Hyperthyroidism; Hypothyroidism; Urinary iodine

Indexed keywords

EID: 66149131845     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302009000100009     Document Type: Article

References (30)

1. Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickam Survey. Clin Endocrinol (Oxf). 1995;43:55-68.
2. Tunbridge WMG, Vanderpump, MPJ. Population screening for autoimmune thyroid disease. Endocrinol Metab Clin North Am. 2000;29:239-53.
3. Wang C, Crapo LM. The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am. 1997;26:189-218.
4. Knobel M, Medeiros-Neto G. Moléstias associadas à carência crônica de iodo. Arq Bras Endocrinol Metab. 2004;48:53-61.
5. Rapoport B, McLachlan SM. Thyroid autoimmunity. J Clin Invest. 2001;108:1253-9.
6. Weetman AP. Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol. 2003;148:1-9.
7. Collins J, Gough S. Autoimmunity in thyroid disease. Eur J Nucl Med. 2002;29:S417-24.
8. Sgarbi JA, Maciel RMB. Patogênese das doenças auto-imunes da tiróide. Arq Bras Endocrinol Metab. 2007; no prelo.
9. Rose NR, Rasooly L, Saboori AM, Burek CL. Linking iodine with autoimmune thyroiditis. Environ Health Perspect. 1999;107:749-52.
10. Prummel MF, Strieder T, Wiersinga WM. The environment and autoimmune thyroid diseases. Eur J Endocrinol. 2004;150:605-18.
11. Maciel RMB. O laboratório no diagnóstico e seguimento de doenças auto-imunes e neoplásicas de tireóide. Arq Bras Endocrinol Metab. 2002; 46:65-71.
12. Esteves RZ. Determinação da excreção urinária de iodo em escolares brasileiros [tese]. São Paulo: Universidade Federal de São Paulo; 1997.
13. Sandell EB, Kolthoff IM. Microdetermination of iodine by a catalytic method. Mikrochemica Acta. 1937;1:9-25.
14. Esteves RZ, Kasamatsu TS, Kunii IS, Furuzawa, GK, Vieira JGH, Maciel RMB. Desenvolvimento de um método para a determinação da iodúria e sua aplicação na excreção urinária de iodo em escolares brasileiros. Arq Bras Endocrinol Metab. 2007;51:1477-84.
15. Dunn JT, Crutchfield HE, Gutekunst R, Dunn AD. Methods for measuring iodine in urine. International Council for Control of Iodine Deficiency Disorders, Wageningen: ICCIDD; 1993.
16. Barros F, Victora C. Inquérito para avaliação da prevalência de bócio em escolares brasileiros. Epicentro: Universidade Federal de Pelotas; 1994.
17. Als C, Minder C, Wellem D, Van Thi HV, Gerber H, Bourdoux P. Quantification of urinary iodine: a need for revised thresholds. Eur J Clin Nutr. 2003;57:1181-8.
18. Dunn JT. Seven deadly sins in confronting endemic iodine deficiency and how to avoid them. J Clin Endocrinol Metab. 1996;81:1332-5.
19. Hetzel BS. Eliminating iodine deficiency disorders-the role of the International Council in the global partnership. Bull World Health Organ. 2002;80:410-7.
20. Iodine status worldwide: World Health Organization (WHO) Global Database on Iodine Deficiency. ISBN 92 4 159200. Disponível em: http://www.who.org.
21. International Council for Control of Iodine Deficiency Disorders. Disponível em: http://www.iccidd.org.
22. Konno N, Makita H, Yuri K, Iizuka N, Kawasaki K. Association between dietary iodine intake and prevalence of subclinical hypothyroidism in the coastal regions of Japan. J Clin Endocrinol Metab. 1994;78:393-7.
23. Pearce EN, Gerber AR, Gootnick DB, Khan LK, Li R, Pino S, et al. Effects of chronic iodine excess in a cohort of long-term American workers in West Africa. J Clin Endocrinol Metab. 2002;87:5499-502.
24. Silva JR, Guariento ME, Fernandes GA, Maciel RMB, Ward LS. Impact of long-term administration of amiodarone on the thyroid function of Chagas' disease patients. Thyroid. 2004;14:373-9.
25. Pavan R, Jesus AMX, Maciel LMZ. A amiodarona e a tireóide. Arq Bras Endocrinol Metab. 2004;48:176-82.
26. Camacho CP, Maciel RMB. Hipotiroidismo/hipertiroidismo durante a terapia com amiodarona. In: Terapêutica Clínica das Doenças Cardiovasculares. São Paulo: FAH Fonseca. 2007.
27. Basaria S, Cooper DS. Amiodarone and the thyroid. Am J Med. 2005;118:706-14.
28. Camargo RYA, Tomimori EK, Neves SC, Knobel M, Medeiros-Neto G. Prevalence of chronic autoimmune thyroiditis in the urban area neighboring a petrochemical complex and a control area in São Paulo, Brazil. Clinics. 2006;61:307-12.
29. Camargo RYA, Tomimori EK, Neves SC, Rubio GS, Galrao AL, Knobel M, et al. Thyroid and the environment: exposure to excessive nutritional iodine increases the prevalence of thyroid disorders in Sao Paulo, Brazil. Eur J Endocrinol. 2008;159:293-9.
30. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295;2164-7.